LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved
LA JOLLA, CA—To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus:
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
New study highlights VP40 as a promising therapeutic target
Haoyang Li, Ph.D., is no stranger to quarantine. He was in high school in China when SARS came knocking. “My
Erica Ollmann Saphire, Ph.D., studies, at the molecular level, how and why viruses are pathogenic. This work provides the roadmap for medical defense.
During the last week of August, the trucks finally started to arrive. Carefully nestled inside 22 huge wooden crates was
LA JOLLA—La Jolla Institute Professor Erica Ollmann Saphire, Ph.D., will lead a five-year global effort totaling up to $35 million
“The beauty of structural biology is that it gives you the ability to dissect the molecular details at high resolution to explain precisely how something works."
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) is honored to announce that Dr. Erica Ollmann Saphire, one of the